A review of 1H MR spectroscopy findings in Alzheimer's disease

Neuroimaging Clinics of North America

Volumn 15, Issue 4, 2005, Pages 847-852

  Soher, Brian J ^a   Doraiswamy, P Murali ^a   Charles, H Cecil ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; DEMENTIA; HUMAN; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; REVIEW; BRAIN; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ALZHEIMER DISEASE; BRAIN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 31544451044     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2005.09.013     Document Type: Review

References (69)

1. H.C. Charles, T. Synderman, and E. Ahearn Magnetic resonance spectroscopy K.R. Krishnan M. Doraiswamy Brain imaging in clinical psychiatry 1997 Marcel Dekker New York 13 23
2. I.R. Young, and H.C. Charles Magnetic resonance spectroscopy: clinical applications and techniques 1996 Martin Dunitz London
3. R. Kreis Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts NMR Biomed 17 2004 361 381
4. B.J. Soher, P. Vermathen, and N. Schuff Short TE in vivo (1)H MR spectroscopic imaging at 1.5 T: acquisition and automated spectral analysis Magn Reson Imaging 18 2000 1159 1165
5. S.W. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn Reson Med 30 1993 672 679
6. A. Naressi, C. Couturier, and J.M. Devos Java-based graphical user interface for the MRUI quantitation package MAGMA 12 2001 141 152
7. B.J. Soher, K. Young, and V. Govindaraju Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging Magn Reson Med 40 1998 822 831
8. K. Young, B.J. Soher, and A.A. Maudsley Automated spectral analysis II: application of wavelet shrinkage for characterization of non-parameterized signals Magn Reson Med 40 1998 816 821
9. T. Bates, M. Strangward, and J. Keelan Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo Neuroreport 7 1995 1397 1400
10. L.L. Cheng, K. Newell, and A.E. Mallory Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetic resonance spectroscopy and stereology Magn Reson Imaging 20 2002 527 533
11. B. Miller A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline NMR Biomed 4 1991 47 52
12. M. Simmons, C. Frondoza, and J. Coyle Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies Neuroscience 45 1991 37 45
13. G. Tsai, and J. Coyle N-acetylaspartate in neuropsychiatric disorders Prog Neurobiol 46 1995 531 540
14. W.M. Brooks, C.A. Stidley, and H. Petropoulos Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study J Neurotrauma 17 2000 629 640
15. De Stefano N., Francis J., Antel D., et al. Reversible decreases of N-acetylaspartate in the brain of patients with relapsing remitting multiple sclerosis. Paper presented at 12th Annual Meeting of the Society for Magnetic Resonance in Medicine. New York, New York, August 1993
16. N. De Stefano, D. Matthews, and D. Arnold Reversible decreases in N-acetylaspartate after acute brain injury Magn Reson Med 34 1995 721 727
17. J.W. Hugg, R.I. Kuzniecky, and F.G. Gilliam Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging Ann Neurol 40 1996 236 239
18. S. Kalra, N.R. Cashman, and A. Genge Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy Neruroreport 9 1998 1757 1761
19. A. Salvan, J. Vion-Dury, and S. Confort-Gouny Brain proton magnetic resonance spectroscopy in HIV-related encephalopathy: identification of evolving metabolic patterns in relation to dementia and therapy AIDS Res Hum Retroviruses 13 1997 1055 1066
20. J. Vion-Dury, F. Nicoli, and A. Salvan Reversal of brain metabolic alteration with zidovudine detected by proton localised magnetic resonance spectroscopy Lancet 345 1995 60 61
21. K. Bhakoo, and D. Pearce In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo J Neurochem 74 2000 254 262
22. R.A. Moats, T. Ernst, and T.K. Shonk Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease Magn Reson Med 32 1994 110 115
23. L. Chang, T. Ernst, and R. Poland In vivo proton magnetic resonance spectroscopy of the normal aging human brain Life Sci 58 1996 2049 2056
24. S.M. Leary, P.A. Brex, and D.G. MacManus A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis Magn Reson Imaging 18 2000 455 459
25. K.J. Ferguson, A.M. MacLullich, and I. Marshall Magnetic resonance spectroscopy and cognitive function in healthy elderly men Brain 125 Pt 12 2002 2743 2749
26. S. Oppenheimer, N. Bryan, and T. Conturo Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions Magn Reson Med 33 1995 61 68
27. F. Lazeyras, H.C. Charles, and L.A. Tupler Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy Psychiatry Res 82 1998 95 106
28. B. Ross Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites NMR Biomed 4 1991 59 63
29. A. Brand, C. Richter-Landsberg, and D. Leibfritz Multinuclear NMR studies on the energy metabolism of glial and neuronal cells Dev Neurosci 15 1993 289 298
30. K. Strange, F. Emma, and A. Paredes Osmoregulatory changes in myo-inositol content and Na + /myo-inositol cotransport in rat cortical astrocytes Glia 12 1994 35 43
31. M. Doraiswamy, C. Charles, and R. Krishnan Prediction of cognitive decline in early Alzheimer's disease Lancet 352 1998 1678
32. L. Parnetti, R. Tarducci, and O. Presciutti Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging Mech Ageing Dev 97 1997 9 14
33. N. Schuff, A.A. Capizzano, and A.T. Du Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD Neurology 58 2002 928 935
34. K. Kantarci, R.C. Petersen, and B.F. Boeve 1H MR spectroscopy in common dementias Neurology 63 2004 1393 1398
35. O. Kizu, K. Yamada, and H. Ito Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy Neuroradiology 46 2004 277 281
36. B.D. Frederick, I.K. Lyoo, and A. Satlin In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease Prog Neuropsychopharmacol Biol Psychiatry 28 2004 1313 1322
37. G. Rai, J. McConnell, and A. Waldman Brain proton spectroscopy in dementia: an aid to clinical diagnosis Lancet 353 1999 1063 1064
38. S. Chantal, C.M. Braun, and R.W. Bouchard Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease Brain Res 1003 2004 26 35
39. N. Ackl, M. Ising, and Y.A. Schreiber Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease Neurosci Lett 384 2005 23 28
40. B. Miller, R. Moats, and T. Shonk Alzheimer disease: depiction of increased cerebral myoinositol with proton MR spectroscopy Radiology 187 1993 433 437
41. L. Parnetti, D.T. Lowenthal, and O. Presciutti 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease J Am Geriatr Soc 44 1996 133 138
42. Schuff N., Amend D., Capizzano A., et al. NAA reductions in parietal and frontal cortex of Alzheimer's disease. Paper presented at 6th International Society for Magnetic Resonance in Medicine. Sydney, Australia, April 1998
43. T. Ernst, L. Chang, and R. Melchor Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy Radiology 203 1997 829 836
44. W.E. Klunk, K. Panchalingam, and R.J. McClure Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4 Neurobiol Aging 19 1998 511 515
45. W.E. Klunk, K. Panchalingam, and J. Moossy N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: a preliminary proton nuclear magnetic resonance study Neurology 42 1992 1578 1585
46. P. Mohankrishnan, A. Fowler, and J. Vonsattel An in vitro 1H nuclear magnetic resonance study of the temporoparietal cortex of Alzheimer brains Exp Brain Res 102 1995 487 496
47. R.A. Sweet, K. Panchalingam, and J.W. Pettegrew Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology Neurobiol Aging 23 2002 547 553
48. P. Kwo-On-Yuen, R. Newmark, and T. Budinger Brain N-acetyl-L-aspartic acid in Alzheimer's disease: a proton magnetic resonance spectroscopy study Brain Res 667 1994 167 174
49. W. Huang, G.E. Alexander, and L. Chang Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study Neurology 57 2001 626 632
50. K. Kantarci, C.R. Jack Jr, and Y.C. Xu Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study Neurology 55 2000 210 217
51. T. Shonk, R. Moats, and P. Gifford Probable Alzheimer disease: diagnosis with proton MR spectroscopy Radiology 195 1995 65 72
52. D.S. Steffens MRI and MRS in dementia K.R. Krishnan M. Doraiswamy Brain imaging in clinical psychiatry 1997 Marcel Dekker New York 503 533
53. J.M. Constans, D.J. Meyerhoff, and J. Gerson H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia Radiology 197 1995 517 523
54. S. MacKay, F. Ezekiel, and V. Di Sclafani Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging Radiology 198 1996 537 545
55. D. Meyerhoff, S. MacKay, and J. Constans Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging Ann Neurol 36 1994 40 47
56. A. Pfefferbaum, E. Adalsteinsson, and D. Spielman In vivo brain concentration of N-acetyl compounds, creatine, and choline in Alzheimer's disease Arch Gen Psychiatry 56 1999 185 192
57. P. Christensen, A. Schlosser, and O. Henriksen Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease Magn Reson Imaging 13 1995 457 462
58. F. Jessen, W. Block, and F. Traber Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD Neurology 55 2000 684 688
59. K. Kantarci, and C.R. Jack Jr Neuroimaging in Alzheimer disease: an evidence-based review Neuroimaging Clin N Am 13 2003 197 209
60. S.E. Rose, G.I. de Zubicaray, and D. Wang A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression Magn Reson Imaging 17 1999 291 299
61. N. Schuff, D. Amend, and F. Ezekiel Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study Neurology 49 1997 1513 1521
62. P. Bottomley, J. Cousins, and D. Pendrey Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy Radiology 183 1992 695 699
63. R. Burri, P. Bigler, and P. Straehl Brain development: 1H magnetic resonance spectroscopy of rat brain extracts compared with chromatographic methods Neurochem Res 15 1990 1009 1016
64. A. Satlin, N. Bodick, and W.W. Offen Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist Am J Psychiatry 154 1997 1459 1461
65. K. Kantarci, G. Reynolds, and R.C. Petersen Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T AJNR Am J Neuroradiol 24 2003 843 849
66. K. Kantarci, Y. Xu, and M.M. Shiung Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease Dement Geriatr Cogn Disord 14 2002 198 207
67. Waldman A.D., McConnell J.R., Rai G.S., et al Automated proton MRS of the brain at 1.0 T: reproducibility and clinical utility in Alzheimer's disease. Presented at International Society for Magnetic Resonance in Medicine Annual Meeting. Sydney, Australia, April 1998
68. Krishnan K.R., Charles H.C., Doraiswamy P.M. Donepezil effects on NAA measured by magnetic resonance spectroscopy in Alzheimer's disease. Presented at Proceedings of the American College of Neuropsychopharmacology. USA, 1999
69. N. Schuff, F. Ezekiel, and A.C. Gamst Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging Magn Reson Med 45 2001 899 907